Trial
NCT03400254
Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Translational Breast Cancer Research Consortium; Pfizer; Hoosier Cancer Research Network; Breast Cancer Research Foundation
Condition
Breast Cancer
Intervention
Hydroxychloroquine (HCQ)
Why stopped
due to business decision regarding the study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-28